you wait and see.....
because FDA requires PoC and requirements differ for different ailments symptoms and diseases
All four products are same, only difference is
1) under physician nurse supervision
2) using pca
3) self administer
Gale first stop $7.70 (high of 2010) then $10.10 (high of 2009) it will keep climbing
my crystal ball...ahem, based on the positive Phase II clinical trials and moving into Phase 3
when was it published ? 2000 or 2003 ? why so much interest from Hedge Funds and other institutions on old news ?
If Gale dips tomorrow on INSY news buy it
Gale close around $4.30 today... Weekly chart looks good.
this is not clear, I thought NeuVax is a vaccine for the prevention of relapse in breast cancer patients with an immunochemistry (IHC) rating of 1+ or 2+ for HER2/neu protein expression
IHC 1+ or IHC 2+ could be for NN ( node negative ) and NP ( node positive )
herceptin works on NP IHC 3+
Now the question is does NeuVax work on both NP NN IHC 1+ and 2+
Phase II showed good results on NN IHC1+ IHC2+
Please correct me if i am mistaken